Post-treatment HBsAg decline predicts high rate of HBsAg loss after stopping entecavir or tenofovir in HBeAg-negative patients without retreatment.
Dig Liver Dis
; 55(9): 1223-1229, 2023 09.
Article
in En
| MEDLINE
| ID: mdl-36870864
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Hepatitis B e Antigens
/
Hepatitis B Surface Antigens
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Dig Liver Dis
Journal subject:
GASTROENTEROLOGIA
Year:
2023
Document type:
Article
Country of publication:
Países Bajos